Four days of sessions on elections, policies, COVID-19 and more comprised the 2020 NCBIO Annual Meeting held Sept. 29 to Oct. 2.
“We are living through extraordinary challenges,” BIO CEO Dr. Michelle McMurry-Heath said during the closing session of NCBIO Annual Meeting. “I hope it is a turning point in the public’s understanding of why science matters. Biotech and science are the catalysts that will ensure we come out of this pandemic stronger, healthier and more resilient.”
Gov. Roy Cooper was named BIO’s 2020 Governor of Year by McMurry-Heath during meeting. Cooper said NC has become a home for cell and gene therapy manufacturing, and last year, the state worked with the industry to create 3,600 new jobs.
BIO Vice President Dave Thomas reviewed the industry’s response to COVID-19, noting that more than half of the 764 unique drug programs have originated in the US, and 72% are by small companies.
Great presentations from leaders of Pairwise, Precision Biosciences and Collaborations Pharmaceuticals on new life science technologies during the third session of the NCBIO Annual Meeting followed by a lively panel discussion on innovation in North Carolina.
NCBIO Membership and Government Affairs Director Laura Gunter moderated a lively discussion with Morgan Jackson of Nexus Strategies and Paul Shumaker of Capitol Communications during the opening session of the NCBIO Annual Meeting.
The second day of the Annual Meeting focused on federal policies impacting the life science industry with leaders of national organizations. COVID-19 and drug pricing were key topics for the discussion.
Thanks to all the sponsors of the 2020 Annual Meeting.
Mark Your Calendars